Fatty acids are required for epidermal permeability barrier function.
Open Access
- 1 August 1993
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 92 (2) , 791-798
- https://doi.org/10.1172/jci116652
Abstract
The permeability barrier is mediated by a mixture of ceramides, sterols, and free fatty acids arranged as extracellular lamellar bilayers in the stratum corneum. Whereas prior studies have shown that cholesterol and ceramides are required for normal barrier function, definitive evidence for the importance of nonessential fatty acids is not available. To determine whether epidermal fatty acid synthesis also is required for barrier homeostasis, we applied 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA), an inhibitor of acetyl CoA carboxylase, after disruption of the barrier by acetone or tape stripping. TOFA inhibits epidermal fatty acid by approximately 50% and significantly delays barrier recovery. Moreover, coadministration of palmitate with TOFA normalizes barrier recovery, indicating that the delay is due to a deficiency in bulk fatty acids. Furthermore, TOFA treatment also delays the return of lipids to the stratum corneum and results in abnormalities in the structure of lamellar bodies, the organelle which delivers lipid to the stratum corneum. In addition, the organization of secreted lamellar body material into lamellar bilayers within the stratum corneum interstices is disrupted by TOFA treatment. Finally, these abnormalities in lamellar body and stratum corneum membrane structure are corrected by coapplication of palmitate with TOFA. These results demonstrate a requirement for bulk fatty acids in barrier homeostasis. Thus, inhibiting the epidermal synthesis of any of the three key lipids that form the extracellular, lipid-enriched membranes of the stratum corneum results in an impairment in barrier homeostasis.Keywords
This publication has 22 references indexed in Scilit:
- Lamellar Body Secretory Response to Barrier DisruptionJournal of Investigative Dermatology, 1992
- Structural Basis for the Barrier Abnormality Following Inhibition of HMG CoA Reductase in Murine EpidermisJournal of Investigative Dermatology, 1992
- Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.Journal of Clinical Investigation, 1991
- Regulation of epidermal sphingolipid synthesis by permeability barrier function.Journal of Lipid Research, 1991
- The Regulation and Role of Epidermal Lipid SynthesisPublished by Elsevier ,1991
- Structural and Lipid Biochemical Correlates of the Epidermal Permeability BarrierPublished by Elsevier ,1991
- Cholesterol synthesis is required for cutaneous barrier function in mice.Journal of Clinical Investigation, 1990
- Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements.Journal of Clinical Investigation, 1990
- Inhibition by 5‐(tetradecyloxy)‐2‐furoic acid of fatty acid and cholesterol synthesis in isolated rat hepatocytesLipids, 1977
- ESSENTIAL FATTY ACIDS AND THE SKINBritish Journal of Dermatology, 1976